Related Experiment Video

Updated: Jun 23, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

959

Special Issue "Latest Advances in Nanomedicine Strategies for Different Diseases"

Nagavendra Kommineni1, Veera Ganesh Yerra2

  • 1Center for Biomedical Research (CBR) Population Council, The Rockefeller University, New York, NY 10065, USA.

International Journal of Molecular Sciences
|June 19, 2024
PubMed

Abstract:

We launched this Special Issue amidst the COVID-19 pandemic, spurred by the growing interest in nanotherapeutic formulations for delivering SARS-CoV-2 viral messenger Ribonucleic Acid (mRNA) vaccines [...].

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.8K

Related Experiment Videos

Last Updated: Jun 23, 2025

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy
05:06

Author Spotlight: Advancements in Nanoparticle Technology for Drug Delivery and Immunotherapy

Published on: November 10, 2023

959
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K
Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

15.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K

Articles linked to this work by shared authors, journal, and citation graph.

Implantable medical devices: From basics to state-of-the-art.

Journal of controlled release : official journal of the Controlled Release Society·2026

Immunomodulatory Nanomaterials: Design Strategies, Mechanisms, Biomedical Applications, and Future Perspectives.

Biomedicines·2026

Proteotoxicity and tubular epithelial cell fate in acute kidney injury: Molecular insights and treatment strategies.

Life sciences·2026

Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation.

The American journal of pathology·2026

Biological Nanocarriers in Cancer Therapy: Cutting Edge Innovations in Precision Drug Delivery.

Biomolecules·2025

Extrarenal Benefits of SGLT2 Inhibitors in the Treatment of Cardiomyopathies.

Physiology (Bethesda, Md.)·2024

RETRACTED: Atiq et al. Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson's Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment. Int. J. Mol. Sci. 2023, 24, 9942.

International journal of molecular sciences·2026

RETRACTED: Li et al. Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells. Int. J. Mol. Sci. 2017, 18, 537.

International journal of molecular sciences·2026

Correction: Balan et al. The Diagnostic and Predictive Potential of miR-328 in Atrial Fibrillation: Insights from a Spontaneously Hypertensive Rat Model. Int. J. Mol. Sci. 2025, 26, 3049.

International journal of molecular sciences·2026

Correction: Simbulan-Rosenthal et al. Employing CRISPR-Cas9 to Generate CD133 Synthetic Lethal Melanoma Stem Cells. Int. J. Mol. Sci. 2022, 23, 2333.

International journal of molecular sciences·2026

Correction: Šoša et al. Metabolic Dysfunction-Associated Steatotic Liver Disease Induced by Microplastics: An Endpoint in the Liver-Eye Axis. Int. J. Mol. Sci. 2025, 26, 2837.

International journal of molecular sciences·2026

Correction: Bou Antoun et al. Development and Characterization of Three Novel FGFR Inhibitor Resistant Cervical Cancer Cell Lines to Help Drive Cervical Cancer Research. Int. J. Mol. Sci. 2025, 26, 1799.

International journal of molecular sciences·2026

Bright NIR-II fluorescence lipid membrane probes for labelling of biomimetic nanovesicles with image-guided targeted NIR-II mild photothermal-immunotherapy of orthotopic glioblastoma.

Biomaterials·2026

Nanomedicine and the tumor immune microenvironment in cancer immunotherapy: a bibliometric and knowledge-mapping analysis.

Frontiers in oncology·2026

Actively tunable piezoelectric SERS platform for ultrasensitive and label-free detection of cytomegalovirus in diverse body fluids.

Talanta·2026

Advances in Nanomedicine for Brain Tumors: Overcoming Biological Barriers, Targeting Strategies, and Future Directions.

Current neurology and neuroscience reports·2026

Development and Validation of an Interpretable Prediction Model for IVIG-Resistant Kawasaki Disease: A Multicenter Prospective Cohort Study.

Journal of the American Heart Association·2026

Motivating Medical Innovators: A Qualitative COM-B Analysis of Physician-Scientists Engagement in Biomedical Advancement in Chinese Academic Medical Centers.

Advances in medical education and practice·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us